Inspire Veteinry PTN A (IVPR) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 2, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the filing for Q3 FY2025, filed Nov 12, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the IVPR SEC filings page.
Inspire Veteinry PTN A (IVPR) reported $15.6M in revenue over the twelve months to Sep 30, 2025, down 8.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings.
Revenue has stalled while overhead expands, leaving a highly leveraged balance sheet and negative operating cash flow.
The 2024 deterioration is primarily an operating-cost problem, not a sales collapse: revenue dipped only0.5% from FY2023 while SG&A rose20.5% . That divergence pushed operating margin down 11.4 percentage points, showing that additional spending was not absorbed by the current revenue base.
FY2024 operating cash flow was
Short-term liquidity is tight: the current ratio was 0.2x while liabilities represented
Financial Health Signals
We do not publish a peer-relative financial health score for Inspire Veteinry PTN A, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Inspire Veteinry PTN A scores -3.54, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $36.4M against total assets of $20.2M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Inspire Veteinry PTN A passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.
Inspire Veteinry PTN A reported a net loss of $14.3M while operations used $10.0M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Inspire Veteinry PTN A generated $4.3M in revenue in Q3 2025. This represents an increase of 6.6% from the same quarter a year earlier. Against the prior quarter it is up 0.8%.
Inspire Veteinry PTN A's EBITDA was -$1.6M in Q3 2025, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Inspire Veteinry PTN A reported a net loss of $2.5M in Q3 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q3 2025.
Cash & Balance Sheet
Inspire Veteinry PTN A recorded an outflow of $1.3M in free cash flow in Q3 2025, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Inspire Veteinry PTN A held $576K in cash against $11.8M in long-term debt as of Q3 2025.
Not reported for Q3 2025.
Margins & Returns
Inspire Veteinry PTN A's operating margin was -45.6% in Q3 2025, reflecting core business profitability. This is up 9.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 15.5 percentage points.
Inspire Veteinry PTN A's net profit margin was -58.5% in Q3 2025, showing the share of revenue converted to profit. This is up 27.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 12.3 percentage points.
Inspire Veteinry PTN A's quarterly ROE was -60.6% in Q3 2025: one quarter's net income over shareholder equity, not annualized. This is up 54.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 619.4 percentage points.
Not reported for Q3 2025.
Capital Allocation
Inspire Veteinry PTN A invested $43K in capex in Q3 2025, funding long-term assets and infrastructure. This represents an increase of 70.3% from the same quarter a year earlier. Against the prior quarter it is up 245.5%.
Not reported for Q3 2025.
Not reported for Q3 2025.
IVPR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'25Filing | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'24Filing | Q2'24Filing | Q1'24Filing | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.3M+6.6% | $4.3M-2.4% | $3.6M-24.7% | $3.3M-12.2% | $4.0M-1.7% | $4.4M-2.2% | $4.8M+12.8% | $3.8M |
| SG&A Expenses | $2.4M-18.9% | $2.7M+19.5% | $2.4M-14.9% | $3.3M+50.0% | $3.0M-16.1% | $2.2M+17.7% | $2.9M+59.5% | $2.2M |
| Operating Income | -$2.0Mn/m | -$2.6Mn/m | -$2.0Mn/m | -$1.5Mn/m | -$2.2Mn/m | -$2.4Mn/m | -$2.9Mn/m | -$2.4M |
| EBITDA | -$1.6Mn/m | -$2.4Mn/m | -$1.7Mn/m | -$1.2Mn/m | -$1.9Mn/m | -$2.1Mn/m | -$2.5Mn/m | -$2.1M |
| Net Income | -$2.5Mn/m | -$3.0Mn/m | -$2.4Mn/m | -$4.0Mn/m | -$3.5Mn/m | -$3.4Mn/m | -$3.4Mn/m | -$4.1Mn/m |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Interest Expense, Income Tax, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
IVPR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'25Filing | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'24Filing | Q2'24Filing | Q1'24Filing | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $24.0M+7.0% | $20.8M-5.1% | $20.7M-11.7% | $20.2M-7.3% | $22.4M+5.2% | $21.9M | $23.4M | $21.8M+8.0% |
| Current Assets | $3.8M-14.1% | $1.3M-39.5% | $2.9M-7.6% | $2.0M+49.7% | $4.5M+25.8% | $2.2M | $3.1M | $1.4M-22.4% |
| Cash & Equivalents | $576K-15.4% | $393K+5037.7% | $1.9M+2589.8% | $524K+192.6% | $681K-65.2% | $8K-99.1% | $69K-88.4% | $179K-59.7% |
| Short-Term Investments | N/A | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Inventory | $498K-11.7% | $477K-17.0% | $475K-12.9% | $517K-9.6% | $564K-17.2% | $575K | $546K | $572K-1.8% |
| Accounts Receivable | $29K-75.2% | $184K+362.3% | $4K-98.7% | $41K+42.4% | $116K-52.2% | $40K | $341K | $29K |
| Long-Term Investments | N/A | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Goodwill | $9.1M+13.3% | $9.0M+10.3% | $8.0M-1.5% | $8.0M-1.5% | $8.0M+5.4% | $8.1M | $8.1M | $8.1M+7.0% |
| Total Liabilities | $19.8M+2.2% | $20.4M-18.7% | $17.7M-23.6% | $18.6M-17.5% | $19.4M+4.2% | $25.0M | $23.1M | $22.6M-10.8% |
| Current Liabilities | $9.7M+38.3% | $10.1M-19.0% | $7.5M-11.6% | $8.2M+8.2% | $7.0M+38.0% | $12.4M | $8.5M | $7.6M+4.6% |
| Non-Current Liabilities | $10.1M-18.4% | $10.3M-18.3% | $10.2M-30.6% | $10.4M-30.4% | $12.3M-8.5% | $12.6M | $14.7M | $15.0M-17.0% |
| Long-Term Debt | $11.8M-5.4% | $12.0M-17.6% | $11.5M | $12.0M | $12.4M | $14.6M | N/A | N/A |
| Total Equity | $4.2M+37.6% | $446Kn/m | $3.0M+1013.2% | $1.6Mn/m | $3.0M+11.7% | -$3.1Mn/m | $270Kn/m | -$788Kn/m |
| Retained Earnings | -$44.3Mn/m | -$41.8Mn/m | -$38.8Mn/m | -$36.4Mn/m | -$31.7Mn/m | -$28.2M | -$24.8M | -$21.2Mn/m |
IVPR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'25Filing | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'24Filing | Q2'24Filing | Q1'24Filing | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.3Mn/m | -$898K-700.0% | -$1.4Mn/m | -$678Kn/m | -$6.3Mn/m | $150Kn/m | -$3.2Mn/m | -$755Kn/m |
| Depreciation & Amortization | $330K-2.8% | $258K-24.2% | $275K-20.7% | $309K-8.2% | $340K+8.6% | $341K+12.1% | $347K+16.4% | $337K+23.1% |
| Capital Expenditures | $43K+70.3% | $13K-46.9% | $20K-87.1% | $32K+34.6% | $26K-89.4% | $24K-77.6% | $157K+1020.9% | $24K |
| Free Cash Flow | -$1.3Mn/m | -$911K-822.8% | -$1.4Mn/m | -$709Kn/m | -$6.3Mn/m | $126Kn/m | -$3.3Mn/m | -$778K |
| Investing Cash Flow | -$43Kn/m | -$1.9Mn/m | -$20Kn/m | -$32Kn/m | -$26Kn/m | -$24Kn/m | -$157Kn/m | -$1.5Mn/m |
| Financing Cash Flow | $1.5M-78.5% | $1.3Mn/m | $2.5M-21.4% | $552K-19.2% | $7.0M+80.0% | -$187K-132.5% | $3.2M+579.8% | $683K-89.1% |
| Dividends Paid | N/A | N/A | N/A | $0-100.0% | $0 | $9K | $212K | $137K |
Not reported in any period shown, so not listed: Stock-Based Compensation, Share Buybacks.
IVPR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'25Filing | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'24Filing | Q2'24Filing | Q1'24Filing | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -45.6%+9.6pp | -61.1%-6.5pp | -55.2%+4.1pp | -46.2%+17.3pp | -55.2%+13.5pp | -54.5%-33.7pp | -59.3%-35.8pp | -63.6% |
| Net Margin | -58.5%+27.6pp | -70.8%+6.3pp | -66.4%+4.5pp | -119.4% | -86.2% | -77.1%-49.8pp | -70.8%-34.9pp | -109.5% |
| Return on Equity | -60.6%+54.6pp | -680.0% | -80.4%+1187.6pp | -253.9% | -115.2%+175.5pp | N/A | -1268.0% | N/A |
| Return on Assets | -10.5%+5.0pp | -14.6%+0.9pp | -11.7%+2.9pp | -19.6%-0.6pp | -15.6%+21.4pp | -15.4% | -14.6% | -19.0%-9.4pp |
| Current Ratio | 0.39-0.2x | 0.130.0x | 0.390.0x | 0.25+0.1x | 0.63-0.1x | 0.18 | 0.37 | 0.18-0.1x |
| Debt-to-Equity | 2.82-1.3x | 26.96 | 3.84 | 7.67 | 4.10 | N/A | N/A | N/A |
| Liabilities-to-Equity | 4.75-1.6x | 45.63 | 5.88-79.8x | 11.93 | 6.39-0.5x | N/A | 85.70 | N/A |
| Asset Turnover | 0.180.0x | 0.210.0x | 0.180.0x | 0.160.0x | 0.180.0x | 0.20 | 0.21 | 0.17 |
| FCF Margin | -30.7% | -21.3%-24.1pp | -38.3%+30.5pp | -21.4%-0.8pp | -156.4% | 2.9%+9.6pp | -68.8%-61.3pp | -20.6% |
Not reported in any period shown, so not listed: Gross Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin, FCF Margin.
Note: The current ratio is below 1.0 (0.25), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Inspire Veteinry PTN A IVPR | FY2024 | $16.6M | -$14.3M | -86.0% | $12K | — |
| Dror Ortho-Design Inc DROR | FY2025 | N/A | N/A | N/A | $6.8M | — |
Where Inspire Veteinry PTN A Ranks
Frequently Asked Questions
Inspire Veteinry PTN A (IVPR) reported $16.6M in total revenue for fiscal year 2024. This represents a -0.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Inspire Veteinry PTN A (IVPR) revenue declined by 0.5% year-over-year, from $16.7M to $16.6M in fiscal year 2024.
No, Inspire Veteinry PTN A (IVPR) reported a net loss of $11.9M over the trailing 12 months to September 30, 2025. In fiscal year 2024 it reported a net loss of $14.3M, with a net profit margin of -86.0%.
Inspire Veteinry PTN A (IVPR) had EBITDA of -$7.7M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2024, Inspire Veteinry PTN A (IVPR) had $524K in cash and equivalents against $12.0M in long-term debt.
Inspire Veteinry PTN A (IVPR) had an operating margin of -54.4% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
Inspire Veteinry PTN A (IVPR) had a net profit margin of -86.0% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
Inspire Veteinry PTN A (IVPR) has a return on equity of -913.2% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
Inspire Veteinry PTN A (IVPR) recorded an outflow of $10.2M in free cash flow during fiscal year 2024. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Inspire Veteinry PTN A (IVPR) recorded an outflow of $10.0M in operating cash flow during fiscal year 2024, representing cash used by core business activities.
Inspire Veteinry PTN A (IVPR) had $20.2M in total assets as of fiscal year 2024, including both current and long-term assets.
Inspire Veteinry PTN A (IVPR) invested $238K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
Inspire Veteinry PTN A (IVPR) had a current ratio of 0.25 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
Inspire Veteinry PTN A (IVPR) had a debt-to-equity ratio of 7.67 as of fiscal year 2024. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Inspire Veteinry PTN A (IVPR) had a liabilities-to-equity ratio of 11.93 as of fiscal year 2024, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Inspire Veteinry PTN A (IVPR) had a return on assets of -70.6% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
Inspire Veteinry PTN A (IVPR) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2025). The market capitalization is $12K as of Nov 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Inspire Veteinry PTN A (IVPR) trades at 0.0x sales, its market capitalization divided by $15.6M revenue, trailing 12 months to September 30, 2025. The market capitalization is $12K as of Nov 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
At the end of fiscal year 2024, Inspire Veteinry PTN A (IVPR) held $524K in cash, cash equivalents and investments, and reported an operating cash outflow of $10.0M over that year. Dividing the one by the other, the reported balance equals about 1 month of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Inspire Veteinry PTN A (IVPR) has an Altman Z-Score of -3.54, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Inspire Veteinry PTN A (IVPR) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Inspire Veteinry PTN A (IVPR) reported a net loss of $14.3M while operations used $10.0M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.